retatrutide do Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide—A Game Changer in Obesity

doi: 10.1007/s00125-017-4315-2 135 HeiseTMariADeVriesJHUrvaSLiJPrattEJet al

Micro-dosing allows the body to adapt gradually, fostering long-term metabolic improvements without drastic interventions

Retatrutide Regulatory Status As of June 2026, retatrutide is not approved by the FDA, the EMA, or any other regulatory agency

Consistency in taking these medications is crucial, as interruptions in treatment can lead to rapid weight regain and the need for another slow titration process to reach the maximum dose again.When considering GLP-1 agonist drugs for weight loss, it is essential to weigh the benefits of their efficacy against the financial burden they may impose

Novo Nordisk estimated that perfect adherence, alongside exercise and portion reduction, would result in users losing 16.6 percent of their weight

Gut-Brain Axis: The connection between your gut and brain is significant